Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_assertion type Assertion NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_head.
- NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_assertion wasGeneratedBy ECO_0000203 NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_provenance.
- NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_assertion wasDerivedFrom befree-2016 NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_provenance.
- NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_assertion SIO_000772 17326216 NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_provenance.
- NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_assertion evidence source_evidence_literature NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_provenance.
- NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_assertion description "[Thus, in patients with HCV-related, histologically proven cirrhosis, achievement of a SVR after IFNalpha therapy was associated with a reduction of liver-related mortality lowering both the risk of complications and HCC development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_provenance.